Mapping the Way: Opportunities in Diagnostics

29 September 2010 Past Event

In an era of health reform, diagnostic technologies that focus on prevention and test the viability of expensive treatment options are becoming increasingly valuable to health providers, payers, and patients. Historically, investment in this sector has not seen the vigor demonstrated with medical devices or biotech innovations. However, in today's environment, diagnostics are becoming attractive opportunities for companies looking for collaborations or acquisitions as well as investors looking for cutting-edge technologies, all creating a robust industry on the brink of breaking through to the mainstream.

In this presentation, panelists will:

  • Provide insight on the diagnostic industry on a local and national level
  • Discuss key elements that are reviewed when assessing start-up opportunities
  • Discuss where opportunities exist for maximizing profits
  • Provide new strategies for raising funds in this dynamic marketplace


  • Stephen DiPalma, Chief Financial Officer, Envivo Pharmaceuticals
  • Ronald S. Eppen, Partner, Foley & Lardner LLP
  • Mitchell Sanders, CEO and Founder, ECI Biotech


Review of Recent Whistleblower Developments
30 July 2021
Legal News: Whistleblower Developments
$4.24M Now the Average Cost Per Data Breach!
30 July 2021
Internet, IT & e-Discovery Blog
Podcast Episode 56: All Things Summer Associate Recruiting
30 July 2021
Foley Career Perspectives
Foley Podcast to Live Panel Discussion
29 July 2021
Foley Career Perspectives
30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream